ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE: CLASS 2 RECALL

13th February 2020

Class 2 Recall on Gliclazide Tab 40mg

Accord-UK Limited is recalling all unexpired stock of Gliclazide 40 mg Tablets (Northstar Livery) from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution, obtained during routine stability testing..

Please visit the: MHRA Website .

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
1217223GLICLAZIDE TAB 40MG ALMACCORD-UK LTD (NORTHSTAR LIVERY)GU50
1217231GLICLAZIDE TAB 40MG TEVACCORD-UK LTD (NORTHSTAR LIVERY)GU50
1207596GLICLAZIDE TAB 40MG ACTACCORD-UK LTD (NORTHSTAR LIVERY)GU50
8427023OTCD GLICLAZIDE TAB 40MGACCORD-UK LTD (NORTHSTAR LIVERY)GU50
8107104GLICLAZIDE TAB 40MGACCORD-UK LTD (NORTHSTAR LIVERY)GU50

ALLIANCE DO NOT STOCK. Please return all affected stock to your original supplier for credit.

For stock control enquiries please contact Accord Customer Services Team on 0800 373573.

For medical information enquiries please contact Accord Medical Information Department on 01271 385257.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

11th February 2020

Company-Led Recall on Iohexol Glenmark Pharmaceuticals

As a precautionary measure, Glenmark Pharmaceuticals is recalling the above lots to wholesaler and pharmacy level due to an out of specification result from the ongoing stability studies. The out of specification result for all batches of Iohexol distributed in United Kingdom are up to 4% over the upper specifications limits for content. (105%).

Please visit the: MHRA Website .

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
1223726IOHEXOL 300MG/50MLGLENMARK PHARMACEUTICALS1806007
1223759IOHEXOL 300MG/75MLGLENMARK PHARMACEUTICALS1805752
1223700IOHEXOL 300MG/100MLGLENMARK PHARMACEUTICALS1805640
1223692IOHEXOL 350MG/50MLGLENMARK PHARMACEUTICALS1806771
1223734IOHEXOL 350MG/100MLGLENMARK PHARMACEUTICALS1805641

For medical information enquiries, please contact: Glenmark medical information: Tel: 0800 458 0383 e-mail: medical_information@glenmarkpharma.com

For stock enquiries, please contact: Matthew Jeffery Tel: 01923 202950 | (Extn) 3010 e-mail: Matthew.Jeffery@glenmarkpharma.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

03rd February 2020

Class 2 Recall on Ranitidine Tablets 150mg & 300mg

Medreich Plc is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Please visit the: MHRA Website .

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
7056195RANITIDINE TAB 150MGMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1069087RANITIDINE TAB 150MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
7056203RANITIDINE TAB 300MGMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1069046RANITIDINE TAB 300MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE
1179191RANITIDINE TAB 300MG ACTMEDREICH PLCPLEASE REFER TO THE MHRA LINK ABOVE

For stock control enquiries please contact Medreich Plc Customer Service team on 020 8831 1580 or cs_team@medreich.co.uk

For medical information enquiries please contact Medreich Plc Pharmacovigilance Department on 020 8831 1580 or info@medreich.co.uk .

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

30th January 2020

Class 2 Recall on Levothyroxine 100micrograms/5ml Oral Sol Wockhardt UK Ltd

Wockhardt UK Ltd is recalling specific batches of Levothyroxine 100micrograms/5ml Oral Solution from pharmacies and wholesalers as a precautionary measure due to notification of the impurity liothyronine exceeding the specification limit.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
1181338LEVOTHYROXINE SOL 100MCG/5MLWOCKHARDT UK LTDI53481
I54522
6329643LEVOTHYROXINE SOL SF 100MCG/5MLWOCKHARDT UK LTDI53481
I54522
1152115LEVOTHYROXINE SF 100MCG/5MLWOCKHARDT UK LTDI53481
I54522

For medical Information enquiries, please contact Medical Information on 01978 661261 or email drug.safety@wockhardt.co.uk.

For enquiries relating to stock returns please contact Wockhardt UK Ltd Customer Services on 01978 661261 or email customer.services@wockhardt.co.uk.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

29th January 2020

Class 4 Caution in Use on Finasteride tablets 5mg Dr Reddy's

Dr. Reddy's Laboratories (UK) Ltd has informed us that the Patient Information Leaflet (PIL) for the above batches is missing the special warning and precautions.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch
1147859FINASTERIDE TAB 5MGDR. REDDY'S LABORATORIESPlease refer to MHRA Link
1135516FINASTERIDE TAB 5MGDR. REDDY'S LABORATORIESPlease refer to MHRA Link
1178482FINASTERIDE TAB 5MGDR. REDDY'S LABORATORIESPlease refer to MHRA Link
1133719FINASTERIDE TAB 5MGDR. REDDY'S LABORATORIESPlease refer to MHRA Link
1139989FINASTERIDE TAB 5MGDR. REDDY'S LABORATORIESPlease refer to MHRA Link

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

27th January 2020

Class 2 Recall on Picato 150 Mcg/G Gel / Picato 500 Mcg/G Gel Leo Pharma

LEO Laboratories Ltd (T/A LEO Pharma) is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to concerns on the possible risk of skin malignancy.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3765732PICATO GEL 150MCG/GLEO PHARMA LTDALL STOCK
3765757PICATO GEL 500MCG/GLEO PHARMA LTDALL STOCK
6839252PICATO GEL 150MCG/GOTC DIRECT (PI'S)ALL STOCK
8430241PICATO GEL 500MCG/GOTC DIRECT (PI'S)ALL STOCK

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

For medical information enquiries please contact LEO Pharma Medical Information Department on 01844 347 333 and press 2 for Medical Information, or by email at medical-info.uk@leo-pharma.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

14th January 2020

Class 4 Caution in Use on Zapain Tablets 30/500mg

Advanz Pharma has informed us of a discrepancy on the product packaging for the batches listed within this alert. The discrepancy relates to "capsules" printed at the top right of the packs in error (where this should be tablets). The other product details on the packs including the name, strength and pharmaceutical form of the medicine are correct.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
2734705ZAPAIN TABLETS 30/500MGAdvanz PharmaPLEASE REFER TO THE MHRA LINK ABOVE

For stock control queries please contact on 08708 877025 or customercare@advanzpharma.com.

For any medical information enquires please contact Medical Information Department on the e-mail medicalinformation@advanzpharma.com or telephone on 08700 703033.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This is a caution in use only we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

19th December 2019

Company-Led Recall on PACLITAXEL VIAL 150MG Pfizer

Hospira UK Limited (Pfizer) is recalling the above batch of the Paclitaxel 6 mg/ml concentrate for solution for infusion (150mg/25ml) as a precautionary measure. This is due to a manufacturing issue which could potentially have resulted in a loss of sterility assurance.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
8121204PACLITAXEL VIAL 150MGPFIZER LTDF016842AD

For stock enquiries, please contact your original supplier or local branch of Alliance Healthcare.

For medical information please contact Pfizer Medical Information Department on 01304 616161

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Stock should not be consolidated and returns should be sent back to your original supplier. 

The final date for accepting stock back for credit is 18 March 2020. 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

28th November 2019

Class 2 Recall on Emerade Auto-Injectors Bausch & Lomb UK

Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of the above product due to an error in one component of the autoinjector believed to cause some pens to fail to activate and deliver adrenaline.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3849221EMERADE 150 AUTO-INJECTORBAUSCH & LOMB UKALL STOCK
3849239EMERADE 300 AUTO-INJECTORBAUSCH & LOMB UKALL STOCK
3849247EMERADE 500 AUTO-INJECTORBAUSCH & LOMB UKALL STOCK

Please note that Alliance Healthcare do not stock and as this is a caution in use only we are not accepting stock returns.

For stock enquiries please contact Bausch & Lomb Customer Services: Tel: 0208 781 2991 Email: Pharma_CS@bausch.com.

For medical information enquiries please contact the Pharmacovigilance and Medical Information Officer, Tel: 0208 781 5523, Email: Pharmacovigilance.UK@bausch.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

21st November 2019

Class 2 Recall on Ranitidine 75mg Tabs - Various Liveries

OTC Concepts Ltd, Relconchem Ltd and Noumed Life Sciences Ltd are recalling all unexpired batches of the below products from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential. Medreich Plc are recalling specific batches of the above products from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

 

Please visit the: MHRA Website .

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches
1130608ALMUS RANITIDINE TAB 75MGNOUMED LIFE SCIENCES LIMITEDALL STOCK
2978211GAVILAST H2 TABNOUMED LIFE SCIENCES LIMITEDALL STOCK
ALLIANCE DO NOT STOCKRanitidine 75mg TabletsOTC Concepts LimitedPLEASE REFER TO THE MHRA LINK ABOVE
ALLIANCE DO NOT STOCKRanitidine 75mg TabletsRelonchem LimitedPLEASE REFER TO THE MHRA LINK ABOVE
ALLIANCE DO NOT STOCKPLEASE REFER TO THE MHRA LINK ABOVEMedreich PLCPLEASE REFER TO THE MHRA LINK ABOVE

OTC Concepts Limited For stock control enquiries please contact Customer Service team on +44 (0) 1484 665733 or Warehouse@dalkeithlabs.co.uk. For medical information enquiries please contact Pharmacovigilance Department on +44 (0) 1525 292344 or RanitidinePV@dalkeithlabs.co.uk

Relonchem Limited For stock control enquiries please contact Relonchem Customer Service team on +44 (0) 151 422 1200 or sales@relonchem.com For medical information enquiries please contact Relonchem Pharmacovigilance Department on +44 (0) 151 556 1857 or medicalinformation@relonchem.com

Noumed Life Sciences Limited For stock control enquiries please contact Noumed Life Sciences Limited Customer Service team on +44 (0) 2033998900 or nicole.mascowe@noumed.co.uk For medical information enquiries please contact Noumed Life Sciences Limited Pharmacovigilance Department on Tel +44 (0) 2033998960 or akhtarhms@skayedzan.co.uk

Medreich PLC For stock control enquiries please contact Medreich Plc. Customer Service team on +44 (0) 20 8831 1580 or cs_team@medreich.co.uk For medical information enquiries please contact Medreich Plc. Pharmacovigilance Department on +44 (0) 20 8831 1580 or qagroup@medreich.co.uk .

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.